Cross-sectional Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities

NCT ID: NCT01325948

Last Updated: 2011-07-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

497 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-03-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the effects of Chronic Obstructive Pulmonary Disease (COPD) on daily life activities in patients with COPD and also to determine the socio-demographic profile, daily life style and needs of the patients with COPD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with COPD

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of COPD
* Outpatient treatment for any reason
* Current or ex-smoker

Exclusion Criteria

* An exacerbation of COPD that still lasts or that was experienced within last 3 months
* History of asthma and/or allergic rhinitis
* The presence of another important respiratory disease
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zeynep Goztas

Role: STUDY_DIRECTOR

AstraZeneca Turkey

Mehmet Polatli

Role: PRINCIPAL_INVESTIGATOR

Adnan Menderes University Faculty of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Adana, , Turkey (Türkiye)

Site Status

Research Site

Ankara, , Turkey (Türkiye)

Site Status

Research Site

Antalya, , Turkey (Türkiye)

Site Status

Research Site

Aydin, , Turkey (Türkiye)

Site Status

Research Site

Bartın, , Turkey (Türkiye)

Site Status

Research Site

Bolu, , Turkey (Türkiye)

Site Status

Research Site

Burdur, , Turkey (Türkiye)

Site Status

Research Site

Bursa, , Turkey (Türkiye)

Site Status

Research Site

Gaziantep, , Turkey (Türkiye)

Site Status

Research Site

Gebze, , Turkey (Türkiye)

Site Status

Research Site

Giresun, , Turkey (Türkiye)

Site Status

Research Site

Isparta, , Turkey (Türkiye)

Site Status

Research Site

Istanbul, , Turkey (Türkiye)

Site Status

Research Site

Izmir, , Turkey (Türkiye)

Site Status

Research Site

Karabük, , Turkey (Türkiye)

Site Status

Research Site

Kayseri, , Turkey (Türkiye)

Site Status

Research Site

Konya, , Turkey (Türkiye)

Site Status

Research Site

Manisa, , Turkey (Türkiye)

Site Status

Research Site

Mersin, , Turkey (Türkiye)

Site Status

Research Site

Yozgat, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RTR-XXX-2011/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.